Pulmonary Emphysema Articles & Analysis
6 news found
Chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis, makes breathing difficult for millions of Americans who have been diagnosed with the condition. ...
Respiratory AI solutions from VIDA are used to assess the lung characteristics associated with chronic, complex lung disease, such as COVID-19 related lung damage, chronic obstructive pulmonary disease (COPD), interstitial lung disease, emphysema, and asthma. ...
(“Stemedica”), a San Diego-based biotech company specializing in the manufacture of clinical grade stem cells, announced today that it has signed a Licensing Agreement with Pulthera, LLC for the rights to use, distribute and sell its mesenchymal stem cell technologies in the treatment of COVID-19 and additional pulmonary conditions. The agreement was confirmed today ...
With these solutions, radiologists and pulmonary clinicians across the network are empowered to optimize the process of diagnosing chronic lung disease, enabling them to deliver more precise, personalized treatments. ...
VIDA’s comprehensive suite of AI-powered, lung intelligence solutions gives clinicians quantitative data and impactful visualizations to aid in the management of all major lung diseases, including asthma, emphysema, chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), lung cancer, COVID-19, and more. ...
Chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis, makes breathing difficult for the 16 million Americans who have been diagnosed with the condition. ...